Brenda Mann

Insider Reports History

Location
Waltham, MA
Signature
/s/ Sarah Romano, Attorney-in-Fact*
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brenda Mann:

Company Role Class Num Shares Value Price $ Report Date Ownership
EYEGATE PHARMACEUTICALS INC VP of Research & Development Common Stock 15,136 $10,444 $0.6900 02 Nov 2021 Direct

Insider Reports Filed by Brenda Mann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPRX EYEGATE PHARMACEUTICALS INC 02 Nov 2021 1 -$123 4 VP of Research & Development 03 Nov 2021, 16:16
KPRX EYEGATE PHARMACEUTICALS INC 04 Oct 2021 1 -$125 4 VP of Research & Development 05 Oct 2021, 18:40
KPRX EYEGATE PHARMACEUTICALS INC 02 Sep 2021 1 -$110 4 VP of Research & Development 03 Sep 2021, 16:15
KPRX EYEGATE PHARMACEUTICALS INC 03 Aug 2021 1 -$151 4 VP of Research & Development 04 Aug 2021, 17:45
KPRX EYEGATE PHARMACEUTICALS INC 02 Jul 2021 1 -$570 4 VP of Research & Development 06 Jul 2021, 16:31
KPRX EYEGATE PHARMACEUTICALS INC 04 Jun 2021 1 -$649 4 VP of Research & Development 07 Jun 2021, 17:01